Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Poly Medicure's monitoring agency report for Q4 FY26 highlights deviations in the utilization of QIP funds. Unutilized proceeds amounting to Rs.7,187.58 lakh were invested in hybrid mutual funds with equity exposure, contrary to the QIP placement document. Additionally, manufacturing facility projects, including the SEZ Jaipur project, are delayed, with expenditure now rescheduled to FY27-28.
May 15 2026 20:05:00
Poly Medicure Limited
POLY MEDICURE LIMITED board meeting is scheduled for May 25, 2026. The agenda includes the consideration and approval of the audited financial results for the quarter and financial year ended March 2026, along with a final dividend.
May 14 2026 17:05:00
Poly Medicure Limited
POLY MEDICURE LIMITED board meeting is scheduled for May 25, 2026. The agenda includes the consideration and approval of the audited financial results for the quarter and financial year ended March 2026, along with a final dividend.
May 14 2026 17:05:00
Poly Medicure Limited
Poly Medicure board will convene on May 25, 2026, to consider and approve its audited standalone and consolidated financial results for Q4 FY26 and the full financial year. The board will also deliberate on the recommendation of a final dividend.
May 14 2026 17:05:00
Poly Medicure Limited
Poly Medicure's Board will meet on May 25, 2026, to review and approve the audited financial results for the financial year ended March 31, 2026. The board will also consider recommending a final dividend for the same period.
May 14 2026 17:05:00
Poly Medicure Ltd - 531768 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 25Th May, 2026
Poly Medicure's board will convene on May 25, 2026, to consider and approve the audited financial results and recommend a final dividend for the financial year ended March 31, 2026.
May 14 2026 17:05:00
Poly Medicure Limited
Poly Medicure Limited's wholly-owned subsidiary, Polymed Brazil LTDA, acquired 100% equity in MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA. This acquisition enables Polymed Brazil to commercialize medical devices in Brazil by gaining necessary operating licenses, including for importation and distribution.
Apr 30 2026 20:04:00
Poly Medicure Limited
Poly Medicure's wholly-owned subsidiary, Polymed Brazil LTDA, has acquired 100% equity of MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA for R$180,000. This acquisition secures all necessary operating licenses for Polymed Brazil LTDA to commercialize and distribute medical devices in Brazil.
Apr 30 2026 20:04:00
Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Acquisition
Poly Medicure's wholly-owned subsidiary, Polymed Brazil LTDA, acquired 100% equity in MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA for R$180,000. This acquisition grants Polymed Brazil access to necessary operating licenses for importing and commercializing medical devices in Brazil.
Apr 30 2026 19:04:00
Read More